| | ||||||||||
| 1 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| AZILSARTAN KAMEDOXOMIL (has an active metabolite)
| AZILSARTAN KAMEDOXOMIL | CARDIOVASCULAR | ORAL | SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | AT1 RECEPTOR | Type-1 angiotensin II receptor P30556 (AGTR1_HUMAN) | EMA | |||
| 2 | INN | Class | Route (list) | PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693) | Primary Target and PDB code of Protein-Drug complex | Targets from DrugCentral | Links | |||
| M AZILSARTAN KAMEDOXOMIL (is an active metabolite)
| AZILSARTAN KAMEDOXOMIL | CARDIOVASCULAR | - | Tmax 2.25 HOUR F 60 PERCENT VD 16 LITER PPB 99 PERCENT Cl 0.138 LITER / HOUR HT 11 HOUR | AT1 RECEPTOR | Type-1 angiotensin II receptor P30556 (AGTR1_HUMAN) | EMA | |||
